QuickStats: Prevalence of Past or Present Infection with Hepatitis B Virus Among Adults Aged 18 Years or Older, by Race and Hispanic Origin — National Health and Nutrition Examination Survey, 1999–2018

September 4, 2020

The prevalence of past or present infection with hepatitis B virus among adults aged 18 years or older declined from 5.7% in 1999–2002 to 4.3% in 2015–2018.

A decline among non-Hispanic White (3.5% to 2.1%), non-Hispanic Black (15.6% to 10.8%), and Mexican American (3.5% to 1.8%) adults also occurred over the same period.

Prevalence was higher among non-Hispanic Black adults than among both non-Hispanic White and Mexican American adults for all periods.

Sources: Kruszon-Moran D, Paulose-Ram R, Martin CB, Barker L, McQuillan G. Prevalence and trends in hepatitis B virus infection in the United States, 2015–2018. NCHS Data Brief, no 361. https://www.cdc.gov/nchs/products/databriefs/db361.htm; National Center for Health Statistics, National Health and Nutrition Examination Survey, 1999–2002 to 2015-2018. https://www.cdc.gov/nchs/nhanes/index.htm.

https://www.cdc.gov/mmwr/volumes/69/wr/mm6935a8.htm


Human Papillomavirus Vaccination Among Adults Aged 18−26, 2013−2018

January 7, 2020

A new NCHS report describes trends in self-reported HPV vaccination initiation and completion by selected demographic characteristics among adults aged 18−26.

  • Among adults aged 18−26, the percentage who ever received one or more doses of human papillomavirus (HPV) vaccine increased from 22.1% in 2013 to 39.9% in 2018.
  • The percentage of adults aged 18−26 who received the recommended number of doses of HPV vaccine increased from 13.8% in 2013 to 21.5% in 2018.
  • In 2018, non-Hispanic white adults were more likely than Hispanic adults to have ever received one or more doses of HPV vaccine.
  • Among adults aged 18−26 who ever received one or more doses of HPV vaccine, the majority received the first dose between the ages of 13 and 17 years.